| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |